GeneDx Corp. (WGSWW) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

GeneDx Corp.

NASDAQ: WGSWW · Real-Time Price · USD
0.06
-0.00 (-3.85%)
At close: Jun 09, 2025, 3:38 PM

GeneDx Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-38.58M -52.29M -83.5M -117.47M -135.02M -175.77M -458.75M -494.05M -533.07M -548.98M -280.65M -170.09M -130.51M -245.39M -330.65M -363.62M -317.46M
Depreciation & Amortization
21.98M 21.95M 34.26M 26.53M 31.35M 34.33M 61.68M 63.51M 62.14M 59.31M 31.06M 26.05M 22.71M 21.81M 19.6M 14.11M 8.49M
Stock-Based Compensation
13.57M 9.14M 5.38M 2.17M -825K -326K 1.01M 1.85M 24.46M 41.98M 78.52M 95.26M 72.02M 219.42M 272.61M 254.6M 255.12M
Other Working Capital
8.62M 4.33M 10.27M -8.87M -7.61M -6.11M -4.79M -6.96M -6.24M -4.52M -3.15M -29K -1.29M 123K -2.9M -2.22M -1.14M
Other Non-Cash Items
26.42M 40.44M 37.42M 62.04M 18.31M 779K 195.52M 177.02M 108.41M 92.46M -100.75M -88.28M -11.42M 1.62M 1.37M 580K 388K
Deferred Income Tax
186K -343K -730K -855K -861K -926K -463K -390K -194K -47K -75.32M -198.44M -197.79M -195.97M -120.75M 2.47M 1.82M
Change in Working Capital
-9.59M -17.27M -17.87M -34.04M -39.47M -37.99M -13.69M -10.02M 45.03M 36.13M 40.65M 46.43M 15.28M 8.08M 1.03M 6.02M -8.9M
Operating Cash Flow
-1.9M -28.5M -55.17M -91.75M -140.75M -179.9M -214.69M -262.08M -293.22M -319.15M -306.49M -289.06M -229.72M -190.43M -156.78M -85.84M -60.54M
Capital Expenditures
-11.18M -5.49M -4.82M -4.28M -5.69M -5.71M -6.17M -10.34M -10.87M -14.32M -19.18M -18.52M -19.7M -20.79M -24.59M -20.97M -16.49M
Cash Acquisitions
n/a n/a 147K 400K -8.11M -8.11M -8.26M -8.51M -127M -127M -127M -127M n/a n/a n/a n/a n/a
Purchase of Investments
-78.34M -66.3M -56.46M -77.05M -52.84M -47.67M -43.94M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
49.14M 41.66M 26.65M 27.08M 24.22M 17.77M 16.66M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 147K -103K -103K -103K -250K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-40.38M -30.13M -34.48M -54.1M -42.67M -43.98M -41.95M -18.85M -137.88M -141.33M -146.18M -145.52M -19.7M -20.79M -24.59M -20.97M -16.49M
Debt Repayment
462K n/a 45.39M 45.18M 45.54M 42.95M -4.79M -4.88M -5.48M -3.29M -3.4M -12.26M -12.88M -13.47M -3.58M 6.27M 7.67M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
57.88M 44.16M 242K 156K -135.42M -135.15M 63.21M 63.21M 199.77M 199.5M 856K -282.56M -284.65M -285.49M -285.23M -1.8M -832K
Financial Cash Flow
58.32M 44.16M 60.24M 45.36M 53.14M 186.24M 139.2M 139.46M 330.13M 197.31M 196.22M 696.27M 495.85M 493.73M 503.87M 4.47M 6.84M
Net Cash Flow
16.03M -14.47M -29.49M -100.58M -130.37M -37.72M -117.44M -141.46M -100.96M -263.17M -256.45M 261.69M 246.42M 282.51M 322.5M -102.35M -70.2M
Free Cash Flow
-13.08M -33.99M -59.99M -96.04M -146.44M -185.61M -220.87M -272.42M -304.09M -333.48M -325.66M -307.58M -249.43M -211.22M -181.37M -106.82M -77.03M